SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

XIENCE™ Family of Drug-Eluting Stents

The World's Leading Drug-Eluting Stents (DES), with Unparalleled Clinical Outcomes¹

XIENCE™ Family of Drug-Eluting Stents
Best-in-Class Deliverability

XIENCE Sierra™ Stent — Best In-Class Deliverability2

The XIENCE Sierra™ stent design offers unmatched deliverability, even when treating challenging complex lesions.

Less Force Required to Cross Lesion

XIENCE Sierra™ Stent requires less force than competitors when crossing a lesion:
73% less force than Synergy‡ 64% less force than Resolute Onyx‡

XIENCE Sierra requires 73% less force to cross lesion than Synergy, 64% less force than Resolute Onyx.

Tighter Crimping For Smoother Crossing3

The optimized MULTI-LINK design enables tighter crimping with XIENCE Sierra™ Stent, allowing for smoother crossing.

XIENCE Sierra has a narrower crest and slimmer, more flexible links—allowing for smoother crossing.

Thinner Balloon for Flexibility in Crossing3

The stent design and thinner balloon technology enhance flexibility and further lower the crimped profile. Among the other features allowing for excellent deliverability is a single-piece outer member for added pushability and trackability.

XIENCE Sierra Stent has a thinner balloon, allowing even lower crimped profile.

Ultra Low Stent Crossing Profile of 0.039"4

The ultra low stent crossing profile, at 0.039", is another factor enabling ease of crossing.

XIENCE DES has an ultra low crossing profile compared to competitors.

More XIENCE Sierra™ Stent features

Expanded Treatment Options
Unparalled Safety
XIENCE Sierra Stent features
Manuals & Technical Resources

Manuals & Technical Resources

Order Cardiovascular Products

Cardiovascular Products

Customer Service

Customer Service

References

  1. Zanchin C, et al. JACC Cardiovasc Interv. 2019;12(17):1665-1675. Serruys P, et al. N Engl J Med. 2010;363:136-146. Shiomi H, et al. JACC Cardiovasc Interv. 2019;12:637-647. Kufner S, et al. Circulation. 2019:139(3):325-333. Palmerini T, et al. Lancet. 2013;379:1393-1402. Bangalore S, et al. Circulation. 2012;125:2873-2891. Bangalore S, et al. Circ Cardiovasc Interv. 2013;6(6):378-390. Pilgrim T, et al. Lancet. 2014;384:2111-2122. Pilgrim T, et al. Lancet. 2018;392:737-746. Data on file at Abbott.
  2. Tests performed and data on file at Abbott. XIENCE Sierra™ showed better crossability with no difference in trackability and pushability compared to Resolute Onyx‡ and SYNERGY‡ stents. Bench test results may not necessarily be indicative of clinical performance. XIENCE Sierra™ (3.0 x 18 mm, n=5), SYNERGY‡ (3.0 x 20 mm, n=5), Resolute Onyx‡ (3.0 x 18 mm, n=5). Catheter performance crossability test measures average force to cross a challenging lesion model.
  3. Data on file at Abbott.
  4. Test performed by and data on file at Abbott. XIENCE Sierra™ (3.0 x 18 mm, n=5), SYNERGY‡ (3.0 x 20 mm, n=5), Resolute Onyx‡ (3.0 x 18 mm, n=5).

MAT-2101790 v1.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-2001111 v7.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0